Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis

Authors not listed

Alnylam Pharmaceuticals · 2014

Abstract

The purpose of this study is to characterize the frequency of TTR mutations in subjects suspected of having cardiac amyloidosis

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2014). DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis. <em>Alnylam Pharmaceuticals</em>. https://clinicaltrials.gov/study/NCT02252653
Vancouver
Anonymous. DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis. Alnylam Pharmaceuticals. 2014.
BibTeX
@misc{anon2014DISCOV, title = {DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis}, author = {Anonymous}, journal = {Alnylam Pharmaceuticals}, year = {2014}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings